<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29052" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Sinus Node Dysfunction</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jabbour</surname>
            <given-names>Fouad</given-names>
          </name>
          <aff>SUNY Upstate University Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kanmanthareddy</surname>
            <given-names>Arun</given-names>
          </name>
          <aff>Creighton University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Fouad Jabbour declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Arun Kanmanthareddy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29052.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Sinus node dysfunction is a disease that is characterized by the inability of the sinoatrial node of producing an adequate heart rate that meets the physiologic needs of an individual. This activity reviews the etiology, diagnostic approach, and management of sinus node dysfunction and highlights the role of interprofessional team members in collaborating to provide well-coordinated care and enhance patient outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology and epidemiology of sinus node dysfunction.</p></list-item><list-item><p>Describe the evaluation of sinus node dysfunction.</p></list-item><list-item><p>Outline the treatment and management options available for sinus node dysfunction.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and communication to advance sinus node dysfunction and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29052&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29052">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29052.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The sinoatrial node (SA) node is the dominant pacemaker of the heart. It is a complex compact region in the junction of superior vena cava and the right atrium. The SA&#x000a0;node depolarizes and produces action potential almost synchronously.<xref ref-type="bibr" rid="article-29052.r1">[1]</xref></p>
        <p>Sinus node dysfunction, also known by its historical name sick sinus syndrome, is the inability of the SA node to produce an adequate heart rate that meets the physiologic needs of the individual. Per definition, sinus node dysfunction should include symptoms and EKG findings&#x000a0;simultaneously such as sinus bradycardia, sinus pauses or arrest, sinus exit blocks, or chronotropic incompetence (inadequate heart rate response to activity). Or the failure of the return of SA nodal activity after electrical cardioversion.<xref ref-type="bibr" rid="article-29052.r2">[2]</xref>&#x000a0;Sinus node dysfunction can be associated with atrial tachycardia as part of the tachycardia-bradycardia syndrome.</p>
      </sec>
      <sec id="article-29052.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Sinus node dysfunction results from the abnormal automaticity, conduction, or both of the sinoatrial node and surrounding tissues. Both could result from abnormal mechanisms, including fibrosis, atherosclerosis, and inflammatory/infiltrative processes.</p>
        <p><bold>Sinus Node Fibrosis:</bold> Replacement of the sinus node tissue by fibrous tissue is the most common cause of sinus node dysfunction, the replacement can also include other parts of the conduction system, including the AV node.<xref ref-type="bibr" rid="article-29052.r3">[3]</xref></p>
        <p><bold>Medication:</bold> Prescription medications can depress the sinus node function, potentially resulting in sinus node dysfunction include: beta blocker, non-dihydropyridine calcium channel blockers, digoxin, antiarrhythmic medications, and acetylcholinesterase inhibitors.<xref ref-type="bibr" rid="article-29052.r4">[4]</xref><xref ref-type="bibr" rid="article-29052.r5">[5]</xref><xref ref-type="bibr" rid="article-29052.r6">[6]</xref><xref ref-type="bibr" rid="article-29052.r7">[7]</xref><xref ref-type="bibr" rid="article-29052.r8">[8]</xref></p>
        <p><bold>Infiltrative disease:</bold> The SA&#x000a0;node tissue can be affected during the disease process of some of the infiltrative diseases such as amyloidosis, sarcoidosis, scleroderma, hemochromatosis, and pericarditis leading to sinus node dysfunction.</p>
        <p><bold>Ischemia:</bold> The sinus node is perfused by the sinoatrial nodal artery, which arises from the right coronary artery in 60 % of the time and from the left circumflex artery in 40 % of the time. Narrowing of this artery can lead to impairment of the sinus node function leading to sinus node dysfunction that can be potentially reversible. Almost all such cases are present in inferior myocardial infarction.<xref ref-type="bibr" rid="article-29052.r9">[9]</xref><xref ref-type="bibr" rid="article-29052.r10">[10]</xref></p>
        <p><bold>Familial:</bold> Sinus node dysfunction in rare cases can be the result of cardiac sodium channel mutations of SCN5A and HCN4 genes.<xref ref-type="bibr" rid="article-29052.r11">[11]</xref></p>
        <p><bold>Miscellaneous:</bold> Other disorders that can rarely cause sinus node dysfunction to include hypothyroidism, hypothermia, and hypoxia.</p>
      </sec>
      <sec id="article-29052.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The study of epidemiology is difficult in sinus node dysfunction due to the variable disease manifestations and ECG findings. However, according to a pooled analysis from two extensive studies that included 20572 patients with a mean age of 59 years old, 43% were males, who researchers followed for an average of 17 years. The incidence of sinus node dysfunction was 0.8 per 1000 person-years. Age showed the greatest significance as a risk factor for having sinus node dysfunction.<xref ref-type="bibr" rid="article-29052.r12">[12]</xref></p>
      </sec>
      <sec id="article-29052.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>To define sinus node dysfunction, both of the symptoms and the EKG findings has to be present. The symptoms of sinus node dysfunction are non-specific and include lightheadedness, fatigue, presyncope, and syncope. For patients who have tachy-brady syndrome, they can present with palpitations. Patients who have other cardiac comorbidities such as coronary artery disease can present with increasing of their baseline ischemic symptoms such as chest pain and dyspnea.</p>
      </sec>
      <sec id="article-29052.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Sick sinus syndrome is defined by the presence of ECG findings and symptoms together, ECG finding alone, especially sinus bradycardia, does not indicate the presence of sick sinus syndrome:</p>
        <p>
<bold>ECG Findings<xref ref-type="bibr" rid="article-29052.r2">[2]</xref><xref ref-type="bibr" rid="article-29052.r13">[13]</xref>:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Periods of inappropriate and often severe sinus bradycardia.</p>
          </list-item>
          <list-item>
            <p>Sinus pauses, sinus arrests and sinus exits blocks that can happen with and without appropriate escape rhythm.</p>
          </list-item>
          <list-item>
            <p>Alternating tachycardia and bradycardia, referred to as a tachy-brady syndrome, which could also be associated with other supraventricular tachycardias.</p>
          </list-item>
        </list>
        <p>The key to diagnosing sinus node dysfunction is to establish a correlation between the patient symptoms and the ECG findings at the time of symptoms. It is also beneficial to review previous ECG tracing to check for any changes in the rhythm upon the start of the symptoms.&#x000a0;</p>
        <p>
<bold>Exercise Stress Testing:</bold>
</p>
        <p>If the diagnosis could not be made based on history, and ECG then exercise stress testing is necessary. Things to look for is the failure of appropriate chronotropic response to exercise, defined as less than 80 percent of the predictable heart rate response to exercise. Also, it will exclude myocardial ischemia and help to program the devices for patients who ultimately receive a permanent pacemaker.<xref ref-type="bibr" rid="article-29052.r14">[14]</xref>.</p>
        <p>
<bold>Ambulatory ECG monitoring:</bold>
</p>
        <p>If all the above failed in making the diagnosis of sinus node dysfunction, then an ambulatory ECG monitoring should be considered. In one study that included 55 symptomatic patients, 24-hour Holter monitor tracking detected the underlying arrhythmia causing the symptoms in 30 patients (55 %).<xref ref-type="bibr" rid="article-29052.r15">[15]</xref> However, longer periods of monitoring might be necessary for patients whom their symptoms are not as frequent. Cardiac event monitors have been shown to be more effective than Holter monitors in detecting the cause of palpitation. In a study involving 43 patients with palpitation, event monitors were twice as likely to provide a diagnostic rhythm strip ECG during symptoms as 48 hours Holter monitors. (67% vs 35%).<xref ref-type="bibr" rid="article-29052.r16">[16]</xref>.</p>
        <p>
<bold>Review of potentially reversible causes:</bold>
</p>
        <p>Patients who are taking medications that can be contributing to their symptoms (beta blocker, calcium channel blockers, digoxin, antiarrhythmic) should be monitored off of these medications and on the ECG monitor to assess for symptoms reversibility as well as the resolution of the ECG findings.<xref ref-type="bibr" rid="article-29052.r14">[14]</xref></p>
      </sec>
      <sec id="article-29052.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The first step in the management of the sinus node dysfunction is to determine whether the patient is hemodynamically stable or no.</p>
        <p>
<bold>Unstable patients:</bold>
</p>
        <p>Patients with sinus node dysfunction are rarely unstable for prolonged periods of time, however, if that was the case then one should follow the ACLS protocol for symptomatic bradycardia.<xref ref-type="bibr" rid="article-29052.r17">[17]</xref> Symptoms include altered mental status, syncope, ischemic chest pain, and hemodynamic instability.</p>
        <p>Atropine should be tried first with a dose of 0.5 mg that can be repeated every 3 to 5 minutes with a total dose of 3 mg. However, treatment with atropine should not delay transcutaneous pacing or chronotropic agents.</p>
        <p>Chronotropic agent infusion should be tried if atropine failure which includes epinephrine, dopamine or isoproterenol infusions.</p>
        <p>Clinicians should initiate transcutaneous pacing in patients who are hemodynamically unstable but should only be a bridge for transvenous pacing.</p>
        <p>
<bold>Stable Patients:</bold>
</p>
        <p>As discussed above, one should look for the possibility of a reversible cause first; If an offending medication was identified and could be removed or replaced, the patient should undergo monitoring for the reversibility of symptoms and ECG findings. If the offending medications cannot be removed. Then the patient should be managed the same way as if there is no reversible cause. The next step involves determining whether the patient is symptomatic or asymptomatic.</p>
        <p>
<bold>Asymptomatic Patient:</bold>
</p>
        <p>Observation is recommended in asymptomatic patients, there are no society guidelines that recommend permanent pacemaker for asymptomatic patients with bradycardia or pauses.<xref ref-type="bibr" rid="article-29052.r14">[14]</xref></p>
        <p>
<bold>Symptomatic Patients:</bold>
</p>
        <p>Symptomatic sinus node dysfunction patients will require placement of a permanent pacemaker. Usually, either single chamber atrial pacemaker (AAI) or dual chamber pacemaker (DDD) should be used. In patients where there are no AV conduction abnormalities, a single chamber atrial pacemaker (AAI) is a reasonable option, however, patients with AV conduction delay or a branch block would benefit from dual chamber pacemaker (DDD).<xref ref-type="bibr" rid="article-29052.r14">[14]</xref></p>
        <p>Discussing the types and modes of pacemaker is beyond the scope of this activity, however, one of the largest trials that looked into single lead atrial pacing (AAI) vs. dual chamber pacing (DDD) in patients with sinus node dysfunction is the DANPACE trail which included 1415 patients with normal AV conduction and the mean follow up&#x000a0;was 5.4 years. There was no difference in all-cause mortality between the two groups, however, Single lead atrial pacing was associated with more incidents of paroxysmal atrial fibrillation and a two-fold increase in pacemaker reoperation.<xref ref-type="bibr" rid="article-29052.r18">[18]</xref></p>
        <p>
<bold>Anticoagulation:</bold>
</p>
        <p>Patients with sinus node dysfunction might have episodes of atrial fibrillation/flutter especially patients with the tachy-brady syndrome. Also, patients who received a permanent pacemaker are at a higher risk of developing atrial fibrillation, thus, frequent device interrogation is recommended. Patients with documented atrial fibrillation should be risk stratified for stroke and bleeding and an informed decision should be made whether to use anticoagulation or no.</p>
      </sec>
      <sec id="article-29052.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Other etiologies of&#x000a0;bradycardia and syncope should be part of the differential diagnosis of sinus node dysfunction such as carotid sinus hypersensitivity, neurocardiogenic syncope with a predominant cardioinhibitory component, sinus bradycardia in conditioned athletes (although does not cause syncope but they do have sinus pauses). Sinus node dysfunction and carotid sinus hypersensitivity can often occur together.<xref ref-type="bibr" rid="article-29052.r19">[19]</xref></p>
      </sec>
      <sec id="article-29052.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Sinus node dysfunction is a progressive noncurable but manageable disease. In a study that followed 52 patients with sinus node dysfunction presenting with sinus bradycardia associated with a sinoatrial block or sinoatrial arrest, it took an average of 13 years to progress to complete the sinoatrial arrest and an escape rhythm.<xref ref-type="bibr" rid="article-29052.r20">[20]</xref>&#x000a0;It is unclear if sinus node dysfunction is associated with increased mortality as most patients with sinus node dysfunction have other cardiovascular comorbidities. In a study of 19000 from two cohorts followed for an average of 17 years, 213 persons developed sinus node dysfunction (0.6 events per 1000 person a year). While the development of sinus node dysfunction carried an association with increased mortality, it became attenuated when adjusted for incident cardiovascular disease. Sinus node dysfunction correlates with increased morbidity, but it is unclear if it affects mortality.<xref ref-type="bibr" rid="article-29052.r21">[21]</xref></p>
      </sec>
      <sec id="article-29052.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Sinus node dysfunction is a noncurable progressive disease. Complications of sinus node dysfunction without a pacemaker include hypotension and syncope.&#x000a0;</p>
      </sec>
      <sec id="article-29052.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Like every other disease, patient education plays a vital role in disease management. Since permanent pacemaker placement is the usual mainstay in this disease, patients should receive training about the importance of maintaining regular follow up with their electrophysiologist to ensure proper pacemaker function with frequent interrogation. Patients also should be educated to recognize the signs of pacemaker malfunction, which include the recurrence of symptoms that they initially presented with such as syncope lightheadedness and fatigue.&#x000a0;</p>
      </sec>
      <sec id="article-29052.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Sinus node dysfunction previously referred to as sick sinus syndrome is a progressive disease that requires both symptoms and ECG findings to diagnose. The mainstay of this disease management is a permanent pacemaker placement. When sinus node dysfunction is associated with atrial arrhythmia, the syndrome then will be called tachycardia-bradycardia syndrome.</p>
      </sec>
      <sec id="article-29052.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>A team approach is necessary for managing patients with sinus node dysfunction. A cardiologist, one who specializes in electrophysiology should be a key member in the team care as almost all patients would require permeant pacemaker placement.<xref ref-type="bibr" rid="article-29052.r18">[18]</xref> (Level I) A primary care provider should also follow the patient along with the cardiologist especially considering that patients with sinus node dysfunction often have other cardiovascular comorbidities that should be managed by the primary care as well as the cardiologist. A specialized nurse also plays a significant role in educating the patient about their disease as well as the functions of their pacemaker, and a board-certified cardiology pharmacist should also review all the patient's medications in light of the case and patient status, and confer with the clinicians for any medication regiment adjustment needed.</p>
        <p>In summary, the diagnosis and management of sinus node dysfunction require an interprofessional team approach, including physicians, specialists, specialty-trained nurses, and pharmacists, all collaborating across disciplines to achieve optimal patient results. [Level 5]</p>
      </sec>
      <sec id="article-29052.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29052&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29052">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/sinus-node-dysfunction-sick-sinus-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29052">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29052/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29052">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29052.s15">
        <title>References</title>
        <ref id="article-29052.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boyett</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Honjo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kodama</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>The sinoatrial node, a heterogeneous pacemaker structure.</article-title>
            <source>Cardiovasc Res</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>47</volume>
            <issue>4</issue>
            <fpage>658</fpage>
            <page-range>658-87</page-range>
            <pub-id pub-id-type="pmid">10974216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferrer</surname>
                <given-names>MI</given-names>
              </name>
            </person-group>
            <article-title>The sick sinus syndrome in atrial disease.</article-title>
            <source>JAMA</source>
            <year>1968</year>
            <month>Oct</month>
            <day>14</day>
            <volume>206</volume>
            <issue>3</issue>
            <fpage>645</fpage>
            <page-range>645-6</page-range>
            <pub-id pub-id-type="pmid">5695590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thery</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gosselin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lekieffre</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Warembourg</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pathology of sinoatrial node. Correlations with electrocardiographic findings in 111 patients.</article-title>
            <source>Am Heart J</source>
            <year>1977</year>
            <month>Jun</month>
            <volume>93</volume>
            <issue>6</issue>
            <fpage>735</fpage>
            <page-range>735-40</page-range>
            <pub-id pub-id-type="pmid">871100</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Margolis</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Strauss</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Digitalis and the sick sinus syndrome. Clinical and electrophysiologic documentation of severe toxic effect on sinus node function.</article-title>
            <source>Circulation</source>
            <year>1975</year>
            <month>Jul</month>
            <volume>52</volume>
            <issue>1</issue>
            <fpage>162</fpage>
            <page-range>162-9</page-range>
            <pub-id pub-id-type="pmid">1132120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strauss</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Svenson</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Electrophysiologic effects of propranolol on sinus node function in patients with sinus node dysfunction.</article-title>
            <source>Circulation</source>
            <year>1976</year>
            <month>Sep</month>
            <volume>54</volume>
            <issue>3</issue>
            <fpage>452</fpage>
            <page-range>452-9</page-range>
            <pub-id pub-id-type="pmid">947574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Breithardt</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Seipel</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wiebringhaus</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Loogen</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Effects of verapamil on sinus node function in man.</article-title>
            <source>Eur J Cardiol</source>
            <year>1978</year>
            <month>Oct</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>379</fpage>
            <page-range>379-94</page-range>
            <pub-id pub-id-type="pmid">710495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vera</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Awan</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>DT</given-names>
              </name>
            </person-group>
            <article-title>Assessment of oral quinidine effects on sinus node function in sick sinus syndrome patients.</article-title>
            <source>Am Heart J</source>
            <year>1982</year>
            <month>Jan</month>
            <volume>103</volume>
            <issue>1</issue>
            <fpage>80</fpage>
            <page-range>80-4</page-range>
            <pub-id pub-id-type="pmid">7055049</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Procainamide-induced sinus node dysfunction in patients with chronic renal failure.</article-title>
            <source>Chest</source>
            <year>1979</year>
            <month>Dec</month>
            <volume>76</volume>
            <issue>6</issue>
            <fpage>699</fpage>
            <page-range>699-701</page-range>
            <pub-id pub-id-type="pmid">92391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hatle</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bathen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rokseth</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Sinoatrial disease in acute myocardial infarction. Long-term prognosis.</article-title>
            <source>Br Heart J</source>
            <year>1976</year>
            <month>Apr</month>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>410</fpage>
            <page-range>410-4</page-range>
            <pub-id pub-id-type="pmid">1267985</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rokseth</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hatle</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Sinus arrest in acute myocardial infarction.</article-title>
            <source>Br Heart J</source>
            <year>1971</year>
            <month>Sep</month>
            <volume>33</volume>
            <issue>5</issue>
            <fpage>639</fpage>
            <page-range>639-42</page-range>
            <pub-id pub-id-type="pmid">5115008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benson</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Dyment</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Knilans</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Fish</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Strieper</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Rhodes</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A).</article-title>
            <source>J Clin Invest</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>112</volume>
            <issue>7</issue>
            <fpage>1019</fpage>
            <page-range>1019-28</page-range>
            <pub-id pub-id-type="pmid">14523039</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jensen</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Gronroos</surname>
                <given-names>NN</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>LY</given-names>
              </name>
              <name>
                <surname>Folsom</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>deFilippi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Heckbert</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Alonso</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Incidence of and risk factors for sick sinus&#x000a0;syndrome in the general population.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2014</year>
            <month>Aug</month>
            <day>12</day>
            <volume>64</volume>
            <issue>6</issue>
            <fpage>531</fpage>
            <page-range>531-8</page-range>
            <pub-id pub-id-type="pmid">25104519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaplan</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Langendorf</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lev</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pick</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Tachycardia-bradycardia syndrome (so-called "sick sinus syndrome"). Pathology, mechanisms and treatment.</article-title>
            <source>Am J Cardiol</source>
            <year>1973</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>497</fpage>
            <page-range>497-508</page-range>
            <pub-id pub-id-type="pmid">4692587</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kusumoto</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Schoenfeld</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Edgerton</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Ellenbogen</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Gold</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Goldschlager</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Joglar</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Marine</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Oken</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Patton</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Pellegrini</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Selzman</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Varosy</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>2018 ACC/AHA/HRS Guideline on the&#x000a0;Evaluation and Management of&#x000a0;Patients With Bradycardia and Cardiac&#x000a0;Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2019</year>
            <month>Aug</month>
            <day>20</day>
            <volume>74</volume>
            <issue>7</issue>
            <fpage>e51</fpage>
            <page-range>e51-e156</page-range>
            <pub-id pub-id-type="pmid">30412709</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lipski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Espinoza</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Motro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dack</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Donoso</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Value of Holter monitoring in assessing cardiac arrhythmias in symptomatic patients.</article-title>
            <source>Am J Cardiol</source>
            <year>1976</year>
            <month>Jan</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>102</fpage>
            <page-range>102-7</page-range>
            <pub-id pub-id-type="pmid">1244726</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kinlay</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leitch</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Neil</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Hardy</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations. A controlled clinical trial.</article-title>
            <source>Ann Intern Med</source>
            <year>1996</year>
            <month>Jan</month>
            <day>01</day>
            <volume>124</volume>
            <issue>1 Pt 1</issue>
            <fpage>16</fpage>
            <page-range>16-20</page-range>
            <pub-id pub-id-type="pmid">7503472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Link</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Berkow</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Kudenchuk</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Halperin</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Hess</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Moitra</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Neumar</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>O'Neil</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Paxton</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Silvers</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Yannopoulos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Donnino</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.</article-title>
            <source>Circulation</source>
            <year>2015</year>
            <month>Nov</month>
            <day>03</day>
            <volume>132</volume>
            <issue>18 Suppl 2</issue>
            <fpage>S444</fpage>
            <page-range>S444-64</page-range>
            <pub-id pub-id-type="pmid">26472995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nielsen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Thomsen</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>H&#x000f8;jberg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>M&#x000f8;ller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vesterlund</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dalsgaard</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mortensen</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Asklund</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Friis</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>Christensen</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Simonsen</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Eriksen</surname>
                <given-names>UH</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>GV</given-names>
              </name>
              <name>
                <surname>Svendsen</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Toff</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Healey</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>HR</given-names>
              </name>
              <collab>DANPACE Investigators</collab>
            </person-group>
            <article-title>A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome.</article-title>
            <source>Eur Heart J</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>686</fpage>
            <page-range>686-96</page-range>
            <pub-id pub-id-type="pmid">21300730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thormann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schwarz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ensslen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sesto</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Vagal tone, significance of electrophysiologic findings and clinical course in symptomatic sinus node dysfunction.</article-title>
            <source>Am Heart J</source>
            <year>1978</year>
            <month>Jun</month>
            <volume>95</volume>
            <issue>6</issue>
            <fpage>725</fpage>
            <page-range>725-31</page-range>
            <pub-id pub-id-type="pmid">655085</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lien</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>FZ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>The sick sinus syndrome: natural history of dysfunction of the sinoatrial node.</article-title>
            <source>Chest</source>
            <year>1977</year>
            <month>Nov</month>
            <volume>72</volume>
            <issue>5</issue>
            <fpage>628</fpage>
            <page-range>628-34</page-range>
            <pub-id pub-id-type="pmid">913143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29052.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alonso</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Lopez</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>LY</given-names>
              </name>
              <name>
                <surname>Psaty</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Folsom</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Heckbert</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Association of sick sinus syndrome with incident cardiovascular disease and mortality: the Atherosclerosis Risk in Communities study and Cardiovascular Health Study.</article-title>
            <source>PLoS One</source>
            <year>2014</year>
            <volume>9</volume>
            <issue>10</issue>
            <fpage>e109662</fpage>
            <pub-id pub-id-type="pmid">25285853</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
